Can an over-the-counter vitamin-like substance slow the progression of Parkinson's disease?
Monday, September 21, 2009 - 14:42
in Health & Medicine
Rush University Medical Center is participating in a large-scale, multi-center clinical trial in the U.S. and Canada to determine whether a vitamin-like substance, in high doses, can slow the progression of Parkinson's disease, a neurodegenerative disorder that affects about one million people in the United States.